Channel Wealth’s AstraZeneca AZN Stock Holding History

Channel Wealth’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.38M	Sell	17,823 -1,662	-9%	-$313K	0.76%	40
2026 Q1	$3.84M	Sell	19,485 -4,492	-19%	-$866K	0.93%	32
2025 Q4	$4.41M	Sell	23,977 -5,277	-18%	-$926K	1.12%	30
2025 Q3	$4.49M	Buy	29,254 +558	+2%	+$84.5K	1.2%	27
2025 Q2	$4.01M	Buy	28,696 +7,449	+35%	+$1.04M	1.13%	27
2025 Q1	$3.12M	Buy	21,247 +1,159	+6%	+$168K	0.97%	34
2024 Q4	$2.63M	Buy	20,088 +11,856	+144%	+$1.66M	0.86%	36
2024 Q3	$1.28M	Sell	8,232 -1,340	-14%	-$216K	0.42%	56
2024 Q2	$1.49M	Sell	9,572 -22,232	-70%	-$3.35M	0.54%	53
2024 Q1	$4.31M	Buy	31,804 +10,677	+51%	+$1.41M	1.73%	16
2023 Q4	$2.85M	Buy	21,127 +2,656	+14%	+$345K	1.34%	25
2023 Q3	$2.5M	Buy	18,471 +9,426	+104%	+$1.29M	1.4%	17
2023 Q2	$1.29M	Buy	9,045 +2,138	+31%	+$315K	0.74%	41
2023 Q1	$959K	Buy	+6,907	New	+$929K	0.62%	48

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Channel Wealth's AZN Position: Q2 2026 in Review

Channel Wealth reduced its AstraZeneca (AZN) stake by 8.5% in Q2 2026, selling an estimated $313K and leaving 17,823 shares worth $3.38M. The position accounts for 0.76% of the portfolio, ranked #40.

Channel Wealth first reported a position in AZN in Q1 2023 and has held it in 14 quarters since. The position peaked at $4.49M in Q3 2025. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Channel Wealth held 17,823 shares of AstraZeneca worth $3.38M as of Q2 2026.
Channel Wealth sold 1,662 AstraZeneca shares in Q2 2026, an estimated $313K.
AstraZeneca made up 0.76% of Channel Wealth's portfolio in Q2 2026, its #40 holding.
Channel Wealth first reported a position in AstraZeneca in Q1 2023 and has held it in 14 quarters since.
Channel Wealth's AstraZeneca position peaked at $4.49M in Q3 2025.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Channel Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.